IBIO Stock Summary and Trading Ideas (Ibio | AMEX:IBIO)

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

Ibio trades on the AMEX stock market under the symbol IBIO.

As of April 24, 2024, IBIO stock price declined to $1.86 with 77,408 million shares trading.

IBIO has a beta of 0.37, meaning it tends to be less sensitive to market movements. IBIO has a correlation of 0.00 to the broad based SPY ETF.

IBIO has a market cap of $16.02 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, IBIO stock traded as high as $975.00 and as low as $1.02.

The top ETF exchange traded funds that IBIO belongs to (by Net Assets): VXF.

IBIO has underperformed the market in the last year with a price return of -92.8% while the SPY ETF gained +24.1%. However, in the short term, IBIO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +72.2% vs +4.5% return in SPY. But in the last 2 weeks, IBIO shares have been beat by the market, returning -14.3% compared to an SPY return of -2.8%.

IBIO support price is $1.71 and resistance is $2.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBIO stock will trade within this expected range on the day.